Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse

被引:45
作者
Kawaguchi, H
Manabe, N
Chikuda, H
Nakamura, K
Kuro-o, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA
关键词
aging; osteoporosis; osteoprotegerin; klotho; bone;
D O I
10.1007/s000180050037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mouse homozygous for a disruption of the klotho locus (KL-/- or klotho mouse) exhibited multiple pathological conditions resembling human aging. We observed osteopenia in KL-/- mice with a low bone turnover, in which the decrease in bone formation exceeded the decrease in bone resorption and resulted in net bone loss. This pathophysiology resembles closely that of senile osteoporosis in humans. Osteoblastic cells from KL-/- mice proliferated normally in vitro; however, they showed much lower alkaline phosphatase activity and mineralized matrix formation than those from control mice. Cultured osteoclastic cells from KL-/- mice had normal resorbing activity and survival rate, but the differentiation of osteoclastic cells from their precursors was significantly disturbed: in the coculture of osteoblastic cells and osteoclast precursor cells, the formation of tartrate-resistant acid phosphatase-positive multinucleated osteoclastic cells was extremely poor only when osteoclast precursor cells originated from KL-/- mice independently of the origin of the osteoblastic cells. In addition, we found that osteoprotegerin a secreted factor which inhibits osteoclastogenesis, was up-regulated in KL-/- mice. We conclude that a defect in klotho gene expression leads to the independent impairment of osteoblast and osteoclast differentiation, which can be a cause of low-turnover osteoporosis.
引用
收藏
页码:731 / 737
页数:7
相关论文
共 15 条
[1]  
FUJIWARA Y, 1985, ADV EXP MED BIOL, V190, P459
[2]   Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence [J].
Jilka, RL ;
Weinstein, RS ;
Takahashi, K ;
Parfitt, AM ;
Manolagas, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1732-1740
[3]   Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [J].
Komori, T ;
Yagi, H ;
Nomura, S ;
Yamaguchi, A ;
Sasaki, K ;
Deguchi, K ;
Shimizu, Y ;
Bronson, RT ;
Gao, YH ;
Inada, M ;
Sato, M ;
Okamoto, R ;
Kitamura, Y ;
Yoshiki, S ;
Kishimoto, T .
CELL, 1997, 89 (05) :755-764
[4]  
KUROO M, 1997, NATURE, V390, P49
[5]   MECHANISMS OF DISEASE - BONE-MARROW, CYTOKINES, AND BONE REMODELING - EMERGING INSIGHTS INTO THE PATHOPHYSIOLOGY OF OSTEOPOROSIS [J].
MANOLAGAS, SC ;
JILKA, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05) :305-311
[6]  
MATSUSHITA M, 1986, AM J PATHOL, V125, P276
[7]   INVOLUTIONAL OSTEOPOROSIS [J].
RIGGS, BL ;
MELTON, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1676-1686
[8]   CYTOGENETICS OF WERNERS SYNDROME CULTURED SKIN FIBROBLASTS - VARIEGATED TRANSLOCATION MOSAICISM [J].
SALK, D ;
AU, K ;
HOEHN, H ;
MARTIN, GM .
CYTOGENETICS AND CELL GENETICS, 1981, 30 (02) :92-107
[9]  
SCHONBERG S, 1984, AM J HUM GENET, V36, P387
[10]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319